6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogoslovskaia, EN; Boĭtsov, SA; Frolov, AA; Golikov, AP; Luk'ianov, MM; Mikhin, VP; Rudnev, DV; Vesel'eva, NV | 1 |
| Bazhukhina, IF; Gapon, LI; Petelina, TI; Savel'eva, NIu; Shurkevich, NP; Vershinina, AM | 1 |
2 trial(s) available for 6-methyl-2-ethyl-3-hydroxypyridine and Blood Pressure, High
| Article | Year |
|---|---|
[Efficacy of cytoprotective agent Mexicor in urgent cardiology].
Topics: Angina, Unstable; Cytoprotection; Drug Therapy, Combination; Echocardiography, Doppler; Heart; Hemodynamics; Humans; Hypertension; Myocardial Contraction; Myocardial Ischemia; Picolines; Vasodilator Agents; Ventricular Function, Left | 2004 |
[Efficacy of emoxipin in treatment of arterial hypertension in the Far North].
Topics: Adult; Antioxidants; Arctic Regions; Blood Pressure; Cell Membrane Permeability; Cold Climate; Environmental Exposure; Erythrocyte Membrane; Humans; Hypertension; Lipid Peroxidation; Male; Middle Aged; Picolines; Siberia; Treatment Outcome | 1999 |